Delivery Order SPE2DB22D3010-SPE2DB24FP3FD

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,874.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract has a completion date of September 5, 2024 and is a firm fixed-price delivery order. This contract is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, will be providing these prescription medications to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 3 mg/0.5 ml pens. The $16,660.01 firm fixed-price delivery order has a completion date of November 7, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical for providing a wide range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $2,902.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Trulicity 4.5 mg/0.5 mL pens. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a...
This federal contract award, valued at $3,051.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 29, 2024. This order is not associated with a set-aside program. As a large supplier of pharmaceutical products and medical supplies to the U.S. government,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The $3,158.40 firm-fixed-price delivery order has an ultimate completion date of August 16, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,824.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price pricing type and a completion date of September 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 3 mg/0.5 mL Trulicity pens. The contract, valued at $2,177.10, is a firm fixed-price delivery order that runs through May 2024. AmerisourceBergen has a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. government. The contract, valued at $87,356.56, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen will deliver the Trulicity medication to support military treatment programs and facilities under this contract, which has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,708.40 firm fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens to support DLA's medical programs. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen, through its Corporate Office division, is a large provider of pharmaceutical products and medical supplies to various government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The contract, valued at $7,460.22, is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. This award is not associated with a set-aside program. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP3FD
    Delivery Order

This federal contract award, valued at $7,402.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Trulicity 3 mg/0.5 ml pens. The contract has a completion date of September 10, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of essential pharmaceutical and medical supplies to support various government healthcare programs and facilities, including military treatment centers. These IDCs enable the government to efficiently procure critical medical commodities from AmerisourceBergen as needed.

Generated 12/9/24, 1:55 PM